Merck
CN
高级检索
Chemical Structure Search
Search Within
文件类型

205-575-3

应用筛选条件
关键词:'205-575-3'
显示 1-30 共 80 条结果 关于 "205-575-3" 范围 技术文档
Data Sheet - SAB4200129
1052-1062 (2005). 2. Pontus, K.A., et al., Eur. J. Biochem., 262, 575-585 (1999). 3. Sun, G.Y., et al., J. Lipid Res., 45, 205-213 (2004). 4. Morgan, N.V., et al., Nat. Genet., 38, 752-754
Data Sheet - SAB4200130
1052-1062 (2005). 2. Pontus, K.A., et al., Eur. J. Biochem., 262, 575-585 (1999). 3. Sun, G.Y., et al., J. Lipid Res., 45, 205-213 (2004). 4. Morgan, N.V., et al., Nat. Genet., 38, 752-754
Product Information Sheet - F6627
thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim. Biophys. Acta, 1587(2-3), 194-205 (2002). 3. Elstein, K. H., et al., Nucleoside-mediated mitigation of 5-fluorouracil-induced toxicity
XP725 Antibody Number-Lot Number 071M4826
523 524 545 546 547 548 569 570 571 572 6.6 501 502 503 504 525 526 527 528 549 550 551 552 573 574 575 576 7.1 577 578 579 580 601 602 603 604 625 626 627 628 649 650
Apoptosis - Antibodies, Reagents and Kits
Caspase 2 Fluorometric 100 assays APT162 $500 Caspase 3 Colorimetric 25 assays APT131 $205 Caspase 3 Colorimetric 100 assays APT165 $390 Caspase 3 Fluorometric 130 assays 17-198 $349 Caspase 5 Colorimetric
PKH Dye Reference Guide
antigen-presenting cells correlate with Th1/Th2-type responses in mice. Immunology 1995; 85: 575-581. 82. Rivas RJ, Hatten ME: Motility and cytoskeletal organization of migrating cerebellar
Product Information Sheet - SH1921
-Cell Activation 242 1469 6.1 SH0521 Tumor Supressors 73 575 7.9 SH2121 Ubiquitin Ligases (E1, E2, E3) 349 2151 6.2 3 Lentiviral Plasmid
Product Information Sheet - SH1821
-Cell Activation 242 1469 6.1 SH0521 Tumor Supressors 73 575 7.9 SH2121 Ubiquitin Ligases (E1, E2, E3) 349 2151 6.2 3 Lentiviral Plasmid
Product Information Sheet - SH2521
-Cell Activation 242 1469 6.1 SH0521 Tumor Supressors 73 575 7.9 SH2121 Ubiquitin Ligases (E1, E2, E3) 349 2151 6.2 3 Lentiviral Plasmid
Product Information Sheet - SH2421
-Cell Activation 242 1469 6.1 SH0521 Tumor Supressors 73 575 7.9 SH2121 Ubiquitin Ligases (E1, E2, E3) 349 2151 6.2 3 Lentiviral Plasmid
Product Information Sheet - SH0221
-Cell Activation 242 1469 6.1 SH0521 Tumor Supressors 73 575 7.9 SH2121 Ubiquitin Ligases (E1, E2, E3) 349 2151 6.2 3 Lentiviral Plasmid
Product Information Sheet - SH2221
-Cell Activation 242 1469 6.1 SH0521 Tumor Supressors 73 575 7.9 SH2121 Ubiquitin Ligases (E1, E2, E3) 349 2151 6.2 3 Lentiviral Plasmid
Product Information Sheet - SH0721
-Cell Activation 242 1469 6.1 SH0521 Tumor Supressors 73 575 7.9 SH2121 Ubiquitin Ligases (E1, E2, E3) 349 2151 6.2 3 Lentiviral Plasmid
Product Information Sheet - SH1021
-Cell Activation 242 1469 6.1 SH0521 Tumor Supressors 73 575 7.9 SH2121 Ubiquitin Ligases (E1, E2, E3) 349 2151 6.2 3 Lentiviral Plasmid
Product Information Sheet - SH0121
-Cell Activation 242 1469 6.1 SH0521 Tumor Supressors 73 575 7.9 SH2121 Ubiquitin Ligases (E1, E2, E3) 349 2151 6.2 3 Lentiviral Plasmid
Product Information Sheet - SH2121
-Cell Activation 242 1469 6.1 SH0521 Tumor Supressors 73 575 7.9 SH2121 Ubiquitin Ligases (E1, E2, E3) 349 2151 6.2 3 Lentiviral Plasmid
Product Information Sheet - SH3021
-Cell Activation 242 1469 6.1 SH0521 Tumor Supressors 73 575 7.9 SH2121 Ubiquitin Ligases (E1, E2, E3) 349 2151 6.2 3 Lentiviral Plasmid
Product Information Sheet - SH1121
-Cell Activation 242 1469 6.1 SH0521 Tumor Supressors 73 575 7.9 SH2121 Ubiquitin Ligases (E1, E2, E3) 349 2151 6.2 3 Lentiviral Plasmid
Product Information Sheet - SH2821
-Cell Activation 242 1469 6.1 SH0521 Tumor Supressors 73 575 7.9 SH2121 Ubiquitin Ligases (E1, E2, E3) 349 2151 6.2 3 Lentiviral Plasmid
Product Information Sheet - SH2921
-Cell Activation 242 1469 6.1 SH0521 Tumor Supressors 73 575 7.9 SH2121 Ubiquitin Ligases (E1, E2, E3) 349 2151 6.2 3 Lentiviral Plasmid
Product Information Sheet - SH0821
-Cell Activation 242 1469 6.1 SH0521 Tumor Supressors 73 575 7.9 SH2121 Ubiquitin Ligases (E1, E2, E3) 349 2151 6.2 3 Lentiviral Plasmid
Product Information Sheet - SH2621
-Cell Activation 242 1469 6.1 SH0521 Tumor Supressors 73 575 7.9 SH2121 Ubiquitin Ligases (E1, E2, E3) 349 2151 6.2 3 Lentiviral Plasmid
Product Information Sheet - SH2721
-Cell Activation 242 1469 6.1 SH0521 Tumor Supressors 73 575 7.9 SH2121 Ubiquitin Ligases (E1, E2, E3) 349 2151 6.2 3 Lentiviral Plasmid
Product Information Sheet - SH2321
-Cell Activation 242 1469 6.1 SH0521 Tumor Supressors 73 575 7.9 SH2121 Ubiquitin Ligases (E1, E2, E3) 349 2151 6.2 3 Lentiviral Plasmid
Product Information Sheet - SH0521
-Cell Activation 242 1469 6.1 SH0521 Tumor Supressors 73 575 7.9 SH2121 Ubiquitin Ligases (E1, E2, E3) 349 2151 6.2 3 Lentiviral Plasmid
Product Information Sheet - SH0421
-Cell Activation 242 1469 6.1 SH0521 Tumor Supressors 73 575 7.9 SH2121 Ubiquitin Ligases (E1, E2, E3) 349 2151 6.2 3 Lentiviral Plasmid
Product Information Sheet - SH1321
-Cell Activation 242 1469 6.1 SH0521 Tumor Supressors 73 575 7.9 SH2121 Ubiquitin Ligases (E1, E2, E3) 349 2151 6.2 3 Lentiviral Plasmid
Product Information Sheet - SH1811
phagocytosis. Methods, 44, 205-21 (2008). 2. Howley, B., and Fearnhead, H.O., Caspases as therapeutic targets. J. Cell Mol. Med., Feb 24 [Epub ahead of print] (2008) 3. Logue, S.E., and Martin
Product Information Sheet - SH2411
phagocytosis. Methods, 44, 205-21 (2008). 2. Howley, B., and Fearnhead, H.O., Caspases as therapeutic targets. J. Cell Mol. Med., Feb 24 [Epub ahead of print] (2008) 3. Logue, S.E., and Martin
Product Information Sheet - SH2211
phagocytosis. Methods, 44, 205-21 (2008). 2. Howley, B., and Fearnhead, H.O., Caspases as therapeutic targets. J. Cell Mol. Med., Feb 24 [Epub ahead of print] (2008) 3. Logue, S.E., and Martin
1/3